Physician profile
Chad E Brekelbaum
NPI 1730145954
$12,901.30
in general payments reported to CMS, 2019-2025
47 companies · $1,683 in 2025
The $1,683 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $684 · 2021: $2,420 · 2022: $2,621 · 2023: $3,805 · 2024: $1,167 · 2025: $1,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,583 · Travel and Lodging: $2,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,583.39 |
| Travel and Lodging | $2,071.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,644.98 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $3,364.65 | 2019-2025 | Lumenis Pulse 120h, Axonics, Ams 700 |
| Procept Biorobotics Corporation | $899.86 | 2020-2025 | Aquabeam Robotic System, Aquabeam System |
| Medtronic, INC. | $478.43 | 2021-2025 | Altaviva, Signia, Interstim |
| Coloplast Corp | $461.99 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $304.08 | 2023-2025 | Orgovyx, Gemtesa |
| Agiliti Health, INC. | $269.60 | 2024-2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Kowa Pharmaceuticals America, INC. | $268.86 | 2022-2023 | Seglentis |
| Teleflex LLC | $236.91 | 2021-2025 | Barrigel |
| Astellas Pharma US INC | $170.96 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $149.00 | 2020-2023 | Prolaris |
| Pfizer INC. | $144.84 | 2023-2025 | |
| Urovant Sciences INC | $122.29 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $115.24 | 2019-2024 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $92.57 | 2021-2025 | Jelmyto |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Brekelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.